Merit Medical Systems
MMSI
Market cap $4.9B

82.91 USD

+0.04

0.05%

At close Jul 30, 4:00 PM EDT

After hours

82.96

+0.05

0.06%

1 day

0.05%

5 days

-2.68%

1 month

-11.31%

3 months

-12.22%

6 months

-24.83%

Year to date

-13.70%

1 year

-2.46%

5 years

78.15%

10 years

229.40%

About: Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Employees: 7,400

Healthcare Medical Instruments & Supplies

0

Funds holding %

of 7,323 funds

0

Analysts bullish %

of 4 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

4,311% more call options, than puts

Call options by funds: $92.8M | Put options by funds: $2.1M

12% more capital invested

Capital invested by funds: $5.9B [Q4 2024] → $6.59B (+$689M) [Q1 2025]

1.3% more ownership

Funds ownership: 104.69% [Q4 2024] → 106.0% (+1.3%) [Q1 2025]

4% more repeat investments, than reductions

Existing positions increased: 139 | Existing positions reduced: 134

0% more funds holding in top 10

Funds holding in top 10: 3 [Q4 2024] → 3 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 51

2% less funds holding

Funds holding: 381 [Q4 2024] → 372 (-9) [Q1 2025]

See Fund Rankings

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$108

30%

upside

Avg. target

$110

32%

upside

High target

$112

35%

upside

4 analyst ratings

4 positive

100%

0 neutral

0%

0 negative

0%

Needham Mike Matson	30%upside $108	Buy Reiterated	18 Jul 2025
Piper Sandler Jason Bednar	33%upside $110	Overweight Maintained	23 May 2025
Canaccord Genuity Jon Young	35%upside $112	Buy Maintained	21 May 2025
Wells Fargo Larry Biegelsen	30%upside $108	Overweight Maintained	21 May 2025

See Analyst Rankings

Financial journalist opinion

Based on 5 articles about MMSI published over the past 30 days

Zacks Investment Research

Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report?

Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report?

Zacks Investment Research

XRAY vs. MMSI: Which Stock Is the Better Value Option?

Investors interested in Medical - Dental Supplies stocks are likely familiar with Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?

XRAY vs. MMSI: Which Stock Is the Better Value Option?

Merit Medical Names Martha Aronson as New President and Chief Executive Officer

Fred Lampropoulos will continue to serve as Chairman of Merit's Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the appointment of Martha Aronson as Merit's new President and Chief Executive Officer, effective October 3, 2025. Fred P. Lampropoulos will remain as Chairman of the Board, President and CEO of Merit through October 3, 2025.

Merit Medical Names Martha Aronson as New President and Chief Executive Officer

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. Merit plans to hold its investor conference call on the same day (Wednesday, July 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

Zacks Investment Research

XRAY or MMSI: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?

XRAY or MMSI: Which Is the Better Value Stock Right Now?

Zacks Investment Research

XRAY vs. MMSI: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?

XRAY vs. MMSI: Which Stock Is the Better Value Option?

The Market Is Vulnerable. 6 ‘Defensive' Stocks to Buy Now.

Stocks that aren't sensitive to economic ups and downs are a smart way to protect your portfolio.

The Market Is Vulnerable. 6 ‘Defensive' Stocks to Buy Now.

Zacks Investment Research

ALGN vs. MMSI: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Align Technology (ALGN) and Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?

ALGN vs. MMSI: Which Stock Should Value Investors Buy Now?

Zacks Investment Research

MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio

Merit Medical aims to provide an additional effective solution that complements a wide range of percutaneous procedures, including interventional radiology and cardiology.

MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio

Merit Medical Acquires Biolife Delaware, L.L.C.

SOUTH JORDAN, Utah, May 20, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that it has acquired Biolife Delaware, L.L.C. (“Biolife”) in a merger transaction through which Biolife has become a wholly-owned subsidiary of Merit. Biolife, which is headquartered in Sarasota, Florida, manufactures unique patented hemostatic devices under the brand names StatSeal and WoundSeal.

Merit Medical Acquires Biolife Delaware, L.L.C.

See News Rankings

Charts implemented using Lightweight Charts™